Brief: Biomea Fusion Announces FDA And Health Canada Clearance Of The Expansion Cohorts Of The Ongoing Covalent-111 Phase Ii Study

Biomea Fusion

28/09/2023 13:38

Sept 28 (Reuters) - Biomea Fusion Inc  BMEA.O :
    * BIOMEA FUSION ANNOUNCES FDA AND HEALTH CANADA CLEARANCE OF
THE
EXPANSION COHORTS OF THE ONGOING COVALENT-111 PHASE II STUDY
    * BIOMEA FUSION- SEES PROVIDING TOPLINE DATA FROM ESCALATION
PHASE
OF COVALENT-111 LATER THIS YEAR

Source text for Eikon:  ID:nGNXb4kHzb 
Further company coverage:  BMEA.O 

 ((Reuters.Briefs@thomsonreuters.com;))